DocGo Inc. (DCGO)
DocGo Inc. provides mobile health and medical transportation services across the United States and the United Kingdom. Their platform delivers healthcare services at home, in offices, and at events, including COVID-19 testing and emergency/non-emergency medical transport.
Company Overview
DocGo is revolutionizing healthcare delivery with its mobile health and medical transportation services, offering a convenient and cost-effective alternative to traditional healthcare settings, positioning it for growth in the expanding telehealth and remote patient monitoring market with a current market cap of $0.08B.
Investment Thesis
DocGo presents a compelling investment opportunity due to its innovative approach to healthcare delivery and its potential to capitalize on the growing demand for mobile health services. The company's platform offers a convenient and cost-effective alternative to traditional healthcare settings, positioning it for growth in the expanding telehealth and remote patient monitoring market. Key value drivers include the expansion of DocGo's service offerings, strategic partnerships with healthcare providers and insurers, and geographic expansion into new markets. While the company currently has a negative P/E ratio of -1.51 and a negative profit margin of -14.0%, the potential for revenue growth and improved profitability is significant as the company scales its operations and achieves greater market penetration. The company's beta of 0.94 suggests a market risk level close to the average.
Key Highlights
- Market Cap of $0.08B reflects the company's current valuation in the competitive healthcare market.
- Gross Margin of 31.2% indicates the profitability of DocGo's core services before operating expenses.
- P/E Ratio of -1.51 suggests the company is currently unprofitable, but reflects growth potential.
- Beta of 0.94 indicates DocGo's stock price is slightly less volatile than the overall market.
- No Dividend Yield reflects the company's focus on reinvesting earnings for growth.
Competitors
Strengths
- Innovative mobile health platform.
- Comprehensive range of services, including medical transportation.
- Strategic partnerships with healthcare providers and insurers.
- Experienced management team.
Weaknesses
- Negative profitability and P/E ratio.
- Relatively small market capitalization.
- Limited geographic presence compared to larger competitors.
- Reliance on partnerships for customer acquisition.
Catalysts
- Ongoing: Expansion of mobile health services into new specialties.
- Upcoming: Announcement of new strategic partnerships with healthcare providers and insurers.
- Ongoing: Geographic expansion into new markets.
- Upcoming: Positive results from clinical trials of new mobile health technologies.
Risks
- Potential: Increased competition from established healthcare providers and telehealth companies.
- Potential: Changes in healthcare regulations and reimbursement policies could negatively impact revenue.
- Ongoing: Economic downturn could reduce healthcare spending.
- Potential: Cybersecurity risks and data breaches could damage reputation and disrupt operations.
- Ongoing: Negative profit margins may deter investors.
Growth Opportunities
- Expansion of Mobile Health Services: DocGo can expand its mobile health service offerings to include a wider range of medical specialties and services, such as chronic disease management, mental health services, and specialized home healthcare. The market for these services is substantial, with the global home healthcare market projected to reach $400 billion by 2027. This expansion would allow DocGo to attract new customers and increase revenue per customer.
- Strategic Partnerships: DocGo can forge strategic partnerships with healthcare providers, insurers, and employers to integrate its mobile health services into existing healthcare ecosystems. These partnerships would provide DocGo with access to a larger customer base and streamline the delivery of its services. The timeline for these partnerships is ongoing, with new partnerships being announced regularly.
- Geographic Expansion: DocGo can expand its operations into new geographic markets, both within the United States and internationally. The demand for mobile health services is growing globally, presenting a significant opportunity for DocGo to expand its reach and impact. The company's existing operations in the United Kingdom provide a solid foundation for further international expansion. This expansion can occur over the next 3-5 years.
- Technological Innovation: DocGo can invest in technological innovation to enhance its mobile health platform and improve the efficiency and effectiveness of its services. This includes developing new mobile apps, integrating wearable devices, and leveraging artificial intelligence to personalize patient care. Investment in technology is an ongoing process.
- Government Contracts: DocGo can pursue government contracts to provide mobile health and medical transportation services to government agencies and beneficiaries. This would provide DocGo with a stable source of revenue and allow it to serve a larger population. Government contracts are typically multi-year agreements and can provide a significant boost to revenue. The timeline for securing these contracts varies depending on the specific opportunity.
Opportunities
- Expansion into new geographic markets.
- Development of new mobile health services.
- Increased adoption of telehealth and remote patient monitoring.
- Government contracts for mobile health services.
Threats
- Competition from traditional healthcare providers and telehealth companies.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn affecting healthcare spending.
- Cybersecurity risks and data breaches.
Competitive Advantages
- Proprietary Technology Platform: DocGo's technology platform provides a seamless and efficient way to connect patients with healthcare providers and manage the delivery of mobile health services.
- Established Network of Healthcare Providers: DocGo has built a network of qualified healthcare providers who are trained to deliver mobile health services.
- First-Mover Advantage: DocGo was one of the first companies to offer mobile health and medical transportation services, giving it a competitive advantage in the market.
- Strategic Partnerships: DocGo has established strategic partnerships with healthcare providers, insurers, and employers, providing it with access to a larger customer base.
About
DocGo, Inc., founded in 2015 and headquartered in New York City, is a leading provider of mobile health and medical transportation services. The company was established to address the growing need for accessible and convenient healthcare solutions, leveraging technology to bring medical services directly to patients. DocGo's initial focus was on providing on-demand medical transportation, including emergency response and non-emergency ambulance and wheelchair services. Over time, the company expanded its service offerings to include a comprehensive mobile health platform. This platform enables DocGo to deliver a wide range of healthcare services at patients' homes and workplaces, including routine check-ups, chronic disease management, and urgent care. A key component of DocGo's growth strategy has been its focus on strategic partnerships with healthcare providers, insurers, and employers. These partnerships allow DocGo to integrate its mobile health services into existing healthcare ecosystems, expanding its reach and impact. DocGo's services extend to event support, offering on-site healthcare at sporting events and concerts. The company operates in the United States and the United Kingdom.
What They Do
- Provides mobile healthcare services at patients' homes and offices.
- Offers medical transportation services, including emergency and non-emergency transport.
- Conducts COVID-19 testing.
- Provides on-site healthcare support at events like sporting events and concerts.
- Offers a technology platform to connect patients with healthcare providers.
- Delivers a range of healthcare services, from routine check-ups to chronic disease management.
Business Model
- Generates revenue through fees for mobile healthcare services.
- Earns revenue from medical transportation services.
- Contracts with healthcare providers, insurers, and employers to provide services to their members/employees.
- Charges fees for on-site healthcare support at events.
Industry Context
DocGo operates within the rapidly evolving healthcare industry, which is experiencing a significant shift towards mobile and remote healthcare solutions. The increasing demand for convenient, accessible, and cost-effective healthcare services is driving the growth of the telehealth and remote patient monitoring markets. DocGo is well-positioned to capitalize on these trends with its mobile health platform and medical transportation services. The competitive landscape includes traditional healthcare providers, telehealth companies, and medical transportation providers. DocGo differentiates itself through its integrated platform, which combines mobile health services with medical transportation, offering a comprehensive solution for patients and healthcare providers.
Key Customers
- Individual patients seeking convenient healthcare services.
- Healthcare providers looking to expand their reach and improve patient access.
- Insurers seeking to reduce healthcare costs and improve member satisfaction.
- Employers looking to provide convenient healthcare services to their employees.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $71M | -$28M | $0.00 |
| Q2 2025 | $80M | -$11M | $0.00 |
| Q1 2025 | $96M | -$9M | $0.00 |
| Q4 2024 | $121M | -$3M | $0.00 |
Source: Company filings
Chart & Info
Price Chart
DocGo Inc. (DCGO) stock price: $0.89 (+0.01, +0.65%)
Why Bull
- •DocGo has recently seen increased insider buying, indicating confidence from leadership in the company's future prospects.
- •Community sentiment has shifted positively, with discussions highlighting the company's innovative healthcare solutions and expanding service offerings.
- •Recent partnerships and contracts have been announced, suggesting a growing market presence and potential revenue growth.
- •Analysts and community members are optimistic about the company's ability to capitalize on the increasing demand for telehealth services.
Why Bear
- •Despite recent positive sentiment, some investors remain cautious due to the competitive landscape in the healthcare sector.
- •Concerns have been raised about the scalability of DocGo's services, with some questioning whether current growth can be sustained long-term.
- •Negative sentiment persists around regulatory challenges that could impact the company's operational flexibility and market entry.
- •There are discussions about potential overvaluation based on future growth expectations, leading to skepticism among more conservative investors.
Latest News
No recent news available for DCGO.
Technical Analysis
Rationale
AI-generated technical analysis for DCGO including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss DocGo Inc. (DCGO) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for DCGO.
Make a Prediction
Set your price target for DocGo Inc. (DCGO), choose a timeframe, and track your prediction accuracy.
Current price: $0.89
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DCGO.
Price Targets
Wall Street price target analysis for DCGO.
Insider Flow (30d)
MoonshotScore
Score Factors
-
Revenue Growth 2/100
Revenue declined -1.2% YoY, signaling shrinking demand or market headwinds.
-
Gross Margin 6/100
Gross margin of 31.2% is acceptable but leaves limited room for R&D and marketing investment.
-
Operating Leverage 4/100
Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.
-
Cash Runway 5/100
Cash position data is currently unavailable for this company.
-
R&D Intensity 5/100
R&D spending data is currently unavailable for this company.
-
Insider Activity 6/100
No significant insider buying or selling recently, which is neutral for the stock outlook.
-
Short Interest 5/100
Float and volume data unavailable for liquidity analysis.
-
Price Momentum 0/100
No bullish technical signals detected. The stock lacks upward price momentum currently.
-
News Sentiment 5/100
No sentiment data available
What does this score mean?
The MoonshotScore rates DCGO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Frequently Asked Questions
What does DocGo Inc. do?
DocGo Inc. is a mobile health company that provides a range of healthcare services directly to patients in their homes, offices, and other locations. They offer medical transportation, including emergency and non-emergency services, as well as a platform for delivering various healthcare services. This includes routine check-ups, chronic disease management, and urgent care. DocGo partners with healthcare providers, insurers, and employers to integrate its services into existing healthcare ecosystems, aiming to improve access to care and reduce costs.
Is DCGO stock a good buy?
DCGO stock presents a mixed investment picture. While the company's innovative mobile health platform and strategic partnerships offer significant growth potential, its current negative profitability and relatively small market capitalization raise concerns. Investors should carefully consider the company's ability to achieve profitability, expand its market share, and manage competition in the rapidly evolving healthcare industry. A thorough analysis of the company's financial performance, growth strategy, and competitive landscape is essential before making an investment decision.
What are the main risks for DCGO?
DocGo faces several key risks, including increasing competition from established healthcare providers and telehealth companies, potential changes in healthcare regulations and reimbursement policies, and the impact of economic downturns on healthcare spending. Cybersecurity risks and data breaches also pose a significant threat to the company's reputation and operations. Additionally, DocGo's current negative profit margins and reliance on partnerships for customer acquisition could hinder its growth and profitability. Investors should carefully assess these risks before investing in DCGO stock.
Is DCGO a good stock to buy?
Whether DCGO is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.
What is the DCGO MoonshotScore?
The MoonshotScore for DCGO is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.
How often is DCGO data updated?
DCGO stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to DCGO is aggregated continuously from premium financial news sources throughout the day.
What are the growth catalysts for DCGO?
Growth catalysts for DocGo Inc. (DCGO) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes DocGo Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.
Who are DCGO's main competitors?
DocGo Inc. (DCGO) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether DCGO has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.
What do analysts say about DCGO?
Wall Street analyst coverage for DCGO includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.
What is DCGO's market cap?
Market capitalization (market cap) for DCGO is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows DCGO's current market cap alongside enterprise value and other valuation metrics.
How has DCGO stock performed recently?
DCGO's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing DCGO's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.
What are the risks of investing in DCGO?
Key risk categories for DCGO include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures DCGO's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.
Are insiders buying or selling DCGO?
Insider trading activity for DCGO tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.
Is DCGO a good stock for beginners?
DocGo Inc. (DCGO) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.
How risky is DCGO for first-time investors?
Every stock carries risk, including DocGo Inc. (DCGO). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like DCGO.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.
- Financial data is based on the most recently available information. The healthcare industry is subject to rapid change and regulatory uncertainty.